chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: tachycardia, numbness and tingling, prickles, gripping sensations in chest and diaphragm that occasionally lead to burning icy hot /acid feeling, pain in different areas of front torso, episodic tachycardia, burning/ hot flashes, weight loss associated with this, occasional pain under right ribs when eating, sensitive to temperature fluctuations, especially cold, easily chilled after episodes.  These symptoms have persisted for 7 months since vaccination with periods of wax and wane and fluctuating severity  multiple treatment trials ranging from integrative treatments using nutriceuticals, Medicine formulas, as well as conventional treatments including antihistamine therapies,  15 day course of prednisone
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Head discomfort, Lacrimation increased, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: I started having a sore throat on 5-12-2022. I done a home test for Covid on 5-14-2022 and it came back positive. The sore throat got worse and I started getting head congestion, runny nose, watery eyes. I woke up on 5-16 and I took some Benadryl, Sudafed and ibuprofen/Tylenol. I called the doctor on 5-17 and I went in that day to be tested and it was positive as well. They did not prescribe anything. They told me they would prescribe something if I was not better by today. I am feeling better. I used a home test for Covid yesterday which still showed positive. I then used a Covid home test today and it was negative. I am reporting my breakthrough case of Covid.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: I started having a sore throat on 5-12-2022. I done a home test for Covid on 5-14-2022 and it came back positive. The sore throat got worse and I started getting head congestion, runny nose, watery eyes. I woke up on 5-16 and I took some Benadryl, Sudafed and ibuprofen/Tylenol. I called the doctor on 5-17 and I went in that day to be tested and it was positive as well. They did not prescribe anything. They told me they would prescribe something if I was not better by today. I am feeling better. I used a home test for Covid yesterday which still showed positive. I then used a Covid home test today and it was negative. I am reporting my breakthrough case of Covid.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Chest discomfort, Chest pain, Electrocardiogram abnormal
Clinical narrative: Patient received moderna vaccine on 2/12/21, 3/13/21 and 11/23/21. COVID positive 5/16/22. Presented to ER on 5/18/22.  Presented to the ed for chest pain, described as pressure x3 days, admitted for chest pain r/o. Patient tested positive for covid at home 5/16. Vitals remarkable for hypertension. Labs with negative troponin x3, iron deficiency anemia and b12 deficiency. cxr unremarkable. Initial EKG in ED with repol abnormality. Repeat EK 5/19 NSR. Discharged on 5/19/22
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Iron deficiency anaemia, SARS-CoV-2 test positive, Troponin normal, Vitamin B12 deficiency
Clinical narrative: Patient received moderna vaccine on 2/12/21, 3/13/21 and 11/23/21. COVID positive 5/16/22. Presented to ER on 5/18/22.  Presented to the ed for chest pain, described as pressure x3 days, admitted for chest pain r/o. Patient tested positive for covid at home 5/16. Vitals remarkable for hypertension. Labs with negative troponin x3, iron deficiency anemia and b12 deficiency. cxr unremarkable. Initial EKG in ED with repol abnormality. Repeat EK 5/19 NSR. Discharged on 5/19/22
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: No treatment.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Eating disorder, Facial paralysis, Headache, Influenza like illness, Lagophthalmos
Clinical narrative: Early the next morning after my 3rd vaccination I lost consciousness and passed out. I had flu like symptoms for the next week. 10 days after my vaccine I started noticing that my face looked strange. A total of 3 weeks (12/11/2021) after the vaccine I developed a weird headache on back of skull. By 12/16/2021 I had trouble eating and my eye wasn't closing. On 12/18/2021 I went to the ER, half of my face was paralyzed. My ER dr referred me to a Neurologist and an Ophthalmologist. I found out that I should see an Optometrist instead of an Ophthalmologist.  From there I was sent to an ENT dr. I'm left with a speech impediment while waiting for my nerves to regenerate I was told that it could take up to a year to heal.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness, Speech disorder
Clinical narrative: Early the next morning after my 3rd vaccination I lost consciousness and passed out. I had flu like symptoms for the next week. 10 days after my vaccine I started noticing that my face looked strange. A total of 3 weeks (12/11/2021) after the vaccine I developed a weird headache on back of skull. By 12/16/2021 I had trouble eating and my eye wasn't closing. On 12/18/2021 I went to the ER, half of my face was paralyzed. My ER dr referred me to a Neurologist and an Ophthalmologist. I found out that I should see an Optometrist instead of an Ophthalmologist.  From there I was sent to an ENT dr. I'm left with a speech impediment while waiting for my nerves to regenerate I was told that it could take up to a year to heal.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Dyspnoea exertional, Epistaxis, Fatigue
Clinical narrative: I contracted COVID-19 on 05/17/2022 with symptoms fever of 101.1 at highest point which I took Tylenol for, scratchy throat, congestion, excessive runny nose, 2 nose bleeds, fatigue, shortness of breath with activity, and chills. I was prescribed Paxlovid, azelastine hydrochloride nasal spray on 05/19/2022. I also took Zyrtec for my runny nose. My runny nose has improved, and fever, chills, scratchy throat have begun to resolve.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: I contracted COVID-19 on 05/17/2022 with symptoms fever of 101.1 at highest point which I took Tylenol for, scratchy throat, congestion, excessive runny nose, 2 nose bleeds, fatigue, shortness of breath with activity, and chills. I was prescribed Paxlovid, azelastine hydrochloride nasal spray on 05/19/2022. I also took Zyrtec for my runny nose. My runny nose has improved, and fever, chills, scratchy throat have begun to resolve.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, COVID-19, Chest discomfort, Cough, Dyspnoea
Clinical narrative: COVID-19 Breakthrough. My husband tested positive the day before I did. I did a home test that morning and it was negative. I went to work and didn't have any symptoms besides my normal cough and shortness of breath. Then while I was there, early to mid afternoon. I noticed my throat was a little sore. I went to take my Flovent inhaler and noticed it hurt a lot and hurt to take a breath. That night at home I was really fatigue, my throat was getting more sore, headache. Body aches started 4 days in. I never really ran a fever, the closest was one day it was 100.6. Tylenol didn't seem to help much. For me it was really the fatigue, then I started to get a very tight chest from day 1 to day 4 by Monday it was a struggle to stay awake. I did have a home O2 monitor by that night my oxygen would drop temporarily to 91. On Tuesday I tried to get a doctors appointment to make sure either was no pneumonia because I am immunocompromised. By Wednesday I was able to contact them and they told me to go to urgent care and they sent me to the ER. I received treatment there. I got the Bebtelovimab treatment. The next day I felt a little better. I still have all my symptoms they are better than they were but still lingering.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Full blood count abnormal, Headache, Metabolic function test abnormal, Oropharyngeal pain
Clinical narrative: COVID-19 Breakthrough. My husband tested positive the day before I did. I did a home test that morning and it was negative. I went to work and didn't have any symptoms besides my normal cough and shortness of breath. Then while I was there, early to mid afternoon. I noticed my throat was a little sore. I went to take my Flovent inhaler and noticed it hurt a lot and hurt to take a breath. That night at home I was really fatigue, my throat was getting more sore, headache. Body aches started 4 days in. I never really ran a fever, the closest was one day it was 100.6. Tylenol didn't seem to help much. For me it was really the fatigue, then I started to get a very tight chest from day 1 to day 4 by Monday it was a struggle to stay awake. I did have a home O2 monitor by that night my oxygen would drop temporarily to 91. On Tuesday I tried to get a doctors appointment to make sure either was no pneumonia because I am immunocompromised. By Wednesday I was able to contact them and they told me to go to urgent care and they sent me to the ER. I received treatment there. I got the Bebtelovimab treatment. The next day I felt a little better. I still have all my symptoms they are better than they were but still lingering.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Pain, Painful respiration, SARS-CoV-2 test positive, Somnolence
Clinical narrative: COVID-19 Breakthrough. My husband tested positive the day before I did. I did a home test that morning and it was negative. I went to work and didn't have any symptoms besides my normal cough and shortness of breath. Then while I was there, early to mid afternoon. I noticed my throat was a little sore. I went to take my Flovent inhaler and noticed it hurt a lot and hurt to take a breath. That night at home I was really fatigue, my throat was getting more sore, headache. Body aches started 4 days in. I never really ran a fever, the closest was one day it was 100.6. Tylenol didn't seem to help much. For me it was really the fatigue, then I started to get a very tight chest from day 1 to day 4 by Monday it was a struggle to stay awake. I did have a home O2 monitor by that night my oxygen would drop temporarily to 91. On Tuesday I tried to get a doctors appointment to make sure either was no pneumonia because I am immunocompromised. By Wednesday I was able to contact them and they told me to go to urgent care and they sent me to the ER. I received treatment there. I got the Bebtelovimab treatment. The next day I felt a little better. I still have all my symptoms they are better than they were but still lingering.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: COVID-19 Breakthrough. My husband tested positive the day before I did. I did a home test that morning and it was negative. I went to work and didn't have any symptoms besides my normal cough and shortness of breath. Then while I was there, early to mid afternoon. I noticed my throat was a little sore. I went to take my Flovent inhaler and noticed it hurt a lot and hurt to take a breath. That night at home I was really fatigue, my throat was getting more sore, headache. Body aches started 4 days in. I never really ran a fever, the closest was one day it was 100.6. Tylenol didn't seem to help much. For me it was really the fatigue, then I started to get a very tight chest from day 1 to day 4 by Monday it was a struggle to stay awake. I did have a home O2 monitor by that night my oxygen would drop temporarily to 91. On Tuesday I tried to get a doctors appointment to make sure either was no pneumonia because I am immunocompromised. By Wednesday I was able to contact them and they told me to go to urgent care and they sent me to the ER. I received treatment there. I got the Bebtelovimab treatment. The next day I felt a little better. I still have all my symptoms they are better than they were but still lingering.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, General physical health deterioration, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Janssen product on 03/31/2021. They tested positive for COVID-19 on 10/14/2021 at the nursing home at which they were a resident. The individual died on 10/19/2021 after a rapid decline in health. The individual was on hospice care at the nursing home for underlying medical conditions.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was  refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by  COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dyskinesia
Clinical narrative: Patient call to say that the evening of the shot , she experience extreme jerking of the body  during  the night . In the morning this condition stopped
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 2.0
Sex: F
Vaccine: DTAP, HEPA
Symptoms: Erythema, Rash, Swelling, Urticaria
Clinical narrative: Patient was brought in with rash all over body, swollen and red feet. Patient diagnosed with Urticaria and prescribed Orapred Solution, 15 MG/5ML, 7 ml PO QD x 3 days, then 3 ml QD x 2 days, Orally, Once a day, 5 days and Syp benadryl 5 ml every 6 hrs x 2 days. Patient told to use Calamine lotion.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Amnesia, Arthropathy, Balance disorder, Impaired work ability, Jaw clicking
Clinical narrative: A couple of months after my vaccine my finger seemed to have pulled back and locked into an pulled back  position without me being able to control it. I have begun to have clicking in my jaw as well, as well as balance issues as well. I have also been having some memory issues as well, when I went to work I was trying to do my routine work however I just kind of went blank and couldn't figure out what I was supposed to be doing. I have been having some memory with issues and I seem to have to look at the address a few times and my short term memory seems to be decreased significantly. For my finger the symptoms have resolved. I get an occasional cramp in my right leg that is very new. Receiving treatment for cancer at this point as well. I feel that I have been getting better in regards to my symptoms and some have been improving.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Joint lock, Memory impairment, Muscle spasms
Clinical narrative: A couple of months after my vaccine my finger seemed to have pulled back and locked into an pulled back  position without me being able to control it. I have begun to have clicking in my jaw as well, as well as balance issues as well. I have also been having some memory issues as well, when I went to work I was trying to do my routine work however I just kind of went blank and couldn't figure out what I was supposed to be doing. I have been having some memory with issues and I seem to have to look at the address a few times and my short term memory seems to be decreased significantly. For my finger the symptoms have resolved. I get an occasional cramp in my right leg that is very new. Receiving treatment for cancer at this point as well. I feel that I have been getting better in regards to my symptoms and some have been improving.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: About 5 minutes after receiving 2nd dose of Pfizer Covid-19 vaccine, patient began to feel dizzy and faint. Patient remained seated and cold compresses were applied. Patient began to feel better within 10 minutes.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Headache, Neck pain
Clinical narrative: Headache, chills, fever, sore shoulder with pain going up into my neck and lower jaw, and swelling on left side of neck, lightheaded, and shaky.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in jaw, Pyrexia, Swelling, Tremor
Clinical narrative: Headache, chills, fever, sore shoulder with pain going up into my neck and lower jaw, and swelling on left side of neck, lightheaded, and shaky.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Scar, Swelling
Clinical narrative: I started getting really itchy on the tops of my feet. Once I started itching it, these bumps started appearing. I started getting itchy on the top of my right hand and top of the wrist. And a little on the forearm. Also, at the back of the forearm/end of forearm. Those were the main areas where I got bumps and itchiness. So, I went to the urgent care, and they weren't completely sure what it was. They said it was probably a rash. He said it looked like bed bug bites, but thought it was probably a rash. So, I was given hydrocortisone cream and I was also given permethrin cream. I was given medication that I only took 5 of prednisone tablets. After a few days, the bumps started subsiding and right now, there's still scars from the bumps. You can see dark spots where the bumps used to be, but the bumps are gone now. It's not itchy anymore. The bumps were also on my legs, I think about the knee. In between the knee and calf. It was mostly on the tops of my feet and on the top of my right hand and forearm. I didn't use most of the mediation, I did use the permethrin cream for the one night I was supposed to, and the hydrocortisone cream a few times. 2-3 times. I probably only took like 2 of the prednisone tablets. The bumps mostly seem to subside without use of the medication. Just over time, a couple days. We never figured out why or how I got the rash. I noted that I didn't eat anything that could really trigger this, so we were unsure of how this happened.
Age: 101.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dental discomfort, Diarrhoea, Dysgeusia, Fatigue
Clinical narrative: On 5/13/2022, I had a very mildly tender throat. On the night of 5/14/2022, I woke up with a splitting sinus headache. I still had a tender throat, and my maxillary teeth were uncomfortable on account of the headache. On the morning of 5/15/2022, I woke up with the same symptoms, so I took an at-home COVID test, and the result was positive. All of the aforementioned symptoms continued, and I also developed a very runny nose and fatigue. My skin throughout my entire body became very sensitive, and it felt like my skin was crawling. The sensation was especially pronounced on my scalp and my back. In the other areas of my body, the skin discomfort was comparatively mild. Hour by hour, my fatigue worsened. At the time of this writing, all of the skin discomfort has subsided. Also, 90% of my headache is gone and my fatigue is 75% better. On 5/16/2022, I began taking Paxlovid and am still taking it. With the Paxlovid, I had diarrhea as a side effect for one day, but the bitter taste side effect has been persistent during the time I have taken the medication. It's hard to say whether the medication is helping, because I don't know how the illness would have progressed had I not taken it. Today, I took a rapid test at the clinic, and the result was still positive.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Formication, Headache, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: On 5/13/2022, I had a very mildly tender throat. On the night of 5/14/2022, I woke up with a splitting sinus headache. I still had a tender throat, and my maxillary teeth were uncomfortable on account of the headache. On the morning of 5/15/2022, I woke up with the same symptoms, so I took an at-home COVID test, and the result was positive. All of the aforementioned symptoms continued, and I also developed a very runny nose and fatigue. My skin throughout my entire body became very sensitive, and it felt like my skin was crawling. The sensation was especially pronounced on my scalp and my back. In the other areas of my body, the skin discomfort was comparatively mild. Hour by hour, my fatigue worsened. At the time of this writing, all of the skin discomfort has subsided. Also, 90% of my headache is gone and my fatigue is 75% better. On 5/16/2022, I began taking Paxlovid and am still taking it. With the Paxlovid, I had diarrhea as a side effect for one day, but the bitter taste side effect has been persistent during the time I have taken the medication. It's hard to say whether the medication is helping, because I don't know how the illness would have progressed had I not taken it. Today, I took a rapid test at the clinic, and the result was still positive.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Sensitive skin, Sinus headache, Skin discomfort, Tenderness
Clinical narrative: On 5/13/2022, I had a very mildly tender throat. On the night of 5/14/2022, I woke up with a splitting sinus headache. I still had a tender throat, and my maxillary teeth were uncomfortable on account of the headache. On the morning of 5/15/2022, I woke up with the same symptoms, so I took an at-home COVID test, and the result was positive. All of the aforementioned symptoms continued, and I also developed a very runny nose and fatigue. My skin throughout my entire body became very sensitive, and it felt like my skin was crawling. The sensation was especially pronounced on my scalp and my back. In the other areas of my body, the skin discomfort was comparatively mild. Hour by hour, my fatigue worsened. At the time of this writing, all of the skin discomfort has subsided. Also, 90% of my headache is gone and my fatigue is 75% better. On 5/16/2022, I began taking Paxlovid and am still taking it. With the Paxlovid, I had diarrhea as a side effect for one day, but the bitter taste side effect has been persistent during the time I have taken the medication. It's hard to say whether the medication is helping, because I don't know how the illness would have progressed had I not taken it. Today, I took a rapid test at the clinic, and the result was still positive.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Slight fever, tired
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Interchange of vaccine products, Lymph node pain, Lymphadenopathy, Nausea
Clinical narrative: I had the Moderna vaccines for my first 3 doses and I have had noticeable nausea but it went away. After I switched to Pfizer that's when the nausea really set in and I have been experiencing it now for five weeks. I also have experienced swollen lymph nodes under both of my arms. I have taken Advil or Ibuprofen and that seem to help with the pain from the lymph nodes. The lymph nodes did resolve after a week. I experienced extreme bloating that has been consistent for the past month. On 05/10/2022 also ended up having a sore throat that only affected the left side of my throat. I saw my doctor and he said he saw a scratch in my throat but didn't find anything stuck. He was unsure as to the cause. I did have fish and I'm unsure if it was a fishbone or not, but it did resolve after about a day and half. The sore throat was gone for about five days, but it has now returned and it is not only on one side of my throat, but my whole upper throat. The lymph nodes in my throat are now swollen. I am experiencing slight congestion as well. I was exposed to a lot of unmasked people while travelling. I will test for COVID-19.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Respiratory tract congestion, Throat irritation
Clinical narrative: I had the Moderna vaccines for my first 3 doses and I have had noticeable nausea but it went away. After I switched to Pfizer that's when the nausea really set in and I have been experiencing it now for five weeks. I also have experienced swollen lymph nodes under both of my arms. I have taken Advil or Ibuprofen and that seem to help with the pain from the lymph nodes. The lymph nodes did resolve after a week. I experienced extreme bloating that has been consistent for the past month. On 05/10/2022 also ended up having a sore throat that only affected the left side of my throat. I saw my doctor and he said he saw a scratch in my throat but didn't find anything stuck. He was unsure as to the cause. I did have fish and I'm unsure if it was a fishbone or not, but it did resolve after about a day and half. The sore throat was gone for about five days, but it has now returned and it is not only on one side of my throat, but my whole upper throat. The lymph nodes in my throat are now swollen. I am experiencing slight congestion as well. I was exposed to a lot of unmasked people while travelling. I will test for COVID-19.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone, Laboratory test abnormal, Thyroiditis, Ultrasound thyroid
Clinical narrative: thyroiditis, treated with beta-blocker, thyroid levels have now returned to normal (note: this event could be just as easily tied to a positive Covid case in early October 2021 or not related to either the vaccine or disease as quite a time lag exists between all of these events)
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by the Regulatory Authority for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Diplopia, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: fever fatigue muscle aches headache onset midnight  Double vision 3pm 5/20/22
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Patient came in today to receive a COVD-19 vaccine. When asked for their vaccination card, they stated it was their first dose. When the patient's name and DOB was searched in immunization registry no account resulted. A full moderna dose (0.5ml) was administered. When attempting to add the patient to immunization registry, an account was found. Immunization registry indicated the patient had a pervious dose of Janssen.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by state for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.